期刊文献+

急性心力衰竭诊断和治疗指南(二) 被引量:18

下载PDF
导出
摘要 上接第8卷第5期急性心力衰竭诊断和治疗指南(一)5急性心衰的治疗5.1治疗目标5.1.1临床评估对患者均应根据上述各种检查方法以及病情变化作出临床评估,包括:
出处 《全科医学临床与教育》 2010年第6期605-615,共11页 Clinical Education of General Practice
  • 相关文献

参考文献25

  • 1Elkayam U,Janmohamed M, Habib M,et al. Vasodilators in the management of acute heart failure[J]. Crit Care Med, 2008, 36(Supple 1):S95-S105.
  • 2Amin A. Hospitalized patients with acute decompensated heart failure:recognition,risk stratification,and treatment review[J].J Hosp M, 2008,3(Suppl 6):S16-S24.
  • 3Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF). Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure:a mdomized controlled trial [J].JAMA, 2002,287(13):1531-1540.
  • 4谢洪智,朱文玲.重组人脑利钠肽和硝酸甘油治疗急性失代偿性心力衰竭疗效和安全性的随机、开放、平行对照的多中心临床研究[J].中华心血管病杂志,2006,34(3):222-226. 被引量:228
  • 5ancy CW,Singh A .Potential applications of outpatient nesiritlda infusions in patients with advanced heart failure and concomitant renal insufficiency[from the Follow-up Serial Infusions of Nesiritide (FUSION I) trial[J].Am J Cardiol, 2006,98(2):226-229.
  • 6Yancy CW,Krum H,Massie BM , et al.The Second Follow- up Serial Infusions of Nesiritide (FUSION 11 ) trial for ad- vanced heart failure:study rationale and design[J].Am Heart J,2007,153 (4):478-484.
  • 7Wang RY,Chow JS,Chan KH, et al. Acute hacmodynamic and myocardial metabolic effects of intravenous urapidil in severe heart faiture[J].Eur Heart J,1984,5(5):745-751.
  • 8Gheorghiade M,Abraham WT,Albert NM, et al.Systolic blood pressure at admission,clinical characteristics,and outcomes in patients hospitalized with acute heart failure [J].JMAM, 2006,296(21 ):2217-2226.
  • 9Havranek EP,Masoudi FA,Wesffall KA , et al.Spectrum of heart failure in older patients:results from the National Heart Failure project[J].Am Heart J,2002,143(4):412-417.
  • 10Rudiger A,Harjola VP,Muller A, et al. Acute heart failure: clinical presentation,one-year mortality and prognostic factors[J].Eur J Heart Fail,2005,7(5):662-670.

二级参考文献9

  • 1Abraham WT,Lowes BD,Ferguson DA,et al.Systemic hemodynamic,neurohormonal,and renal excretory effects of a steady-state infusion of human brain natriuretic peptide in patients with decompensated chronic heart failure.J Card Fail,1998,4:37-44.
  • 2Mills RM,LeJemtel TH,Horton DP,et al.Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure:a randomized,double-blind,placebo-controlled clinical trial.Natrecor Study Group.J Am Coll Cardiol,1999,34:155-162.
  • 3Colucci WS,Elkayam E,Horton DP,et al.Intravenous nesiritide,a natriuretic peptide,in the treatment of decompensated heart failure.N Engl J Med,2000,343:246-253.
  • 4Kawakami R,Saito Y,Kishimoto I,et al.Overexpression of brain natriuretic peptide facilitates neutrophil infiltration and cardiac matrix metalloproteinase-9 expression after acute myocardial infarction.Circulation,2004,110:3306-3312.
  • 5Keating GM,Goa KL.Nesiritide:a review of its use in acute decompensated heart failure.Drugs,2003,63:47-70.
  • 6de Lemos JA,McGuire DK,Drazner MH.B-type natriuretic peptide in cardiovascular disease.Lancet,2003,362:316-322.
  • 7Strain WD.The use of recombinant human B-type natriuretic peptide (nesiritide) in the management of acute decompensated heart failure.Int J Clin Pract,2004,58:1081-1087.
  • 8de Denus S,Pharand C,Williamson DR.Brain natriuretic peptide in the management of heart failure:the versatile neurohormone.Chest,2004,125:652-668.
  • 9Colucci WS.Nesiritide for the treatment of decompensated heart failure.J Card Fail,2001,7:92-100.

共引文献227

同被引文献250

引证文献18

二级引证文献89

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部